First Time Loading...

Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 4.03 USD 4.68% Market Closed
Updated: May 6, 2024

Abcellera Biologics Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Cash from Financing Activities Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Cash from Financing Activities
$10.4m
CAGR 3-Years
-75%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Cash from Financing Activities
CA$626.7k
CAGR 3-Years
-38%
CAGR 5-Years
-22%
CAGR 10-Years
15%
Replicel Life Sciences Inc
XTSX:RP
Cash from Financing Activities
CA$1.9m
CAGR 3-Years
24%
CAGR 5-Years
11%
CAGR 10-Years
6%
Innovotech Inc
XTSX:IOT
Cash from Financing Activities
-CA$60.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Abcellera Biologics Inc's Cash from Financing Activities?
Cash from Financing Activities
10.4m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Cash from Financing Activities amounts to 10.4m USD.

What is Abcellera Biologics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-3%

The average annual Cash from Financing Activities growth rates for Abcellera Biologics Inc have been -75% over the past three years , -3% over the past five years .